Alternate Day Micafungin: A PK Study in Pediatric Patients
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the pharmacokinetics of micafungin when it is given
on an every other day schedule. The study will determine if every other day micafungin will
provide drug exposure equivalent to daily dosing while reducing administration costs and
improving patient convenience. Fifteen patients will be enrolled on this study. Blood samples
for PK measurements will be obtained for 48 hours following a single dose of micafungin (3
mg/kg).